Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunomodulatory Properties of Ketamine in Sepsis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2010 by Beth Israel Deaconess Medical Center.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT01089361
First received: March 12, 2010
Last updated: October 19, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2011
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)